Publications (2)1.32 Total impact
- Journal of drugs in dermatology: JDD 06/2010; 9(6):719-22. · 1.32 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: Staphylococcus aureus infections account for the majority of skin and soft tissue infections in the United States. Staphylococcus aureus is rapidly evolving resistance to contemporary topical as well as systemic antibiotics. Alternatives to current treatment options for skin and soft tissue infections are needed for more effective treatment now and in the future. Nitric oxide's proven roles in both wound repair and as an antimicrobial agent make it an excellent candidate for the treatment of skin infections. Recent attempts at novel nitric oxide therapies, in the form of nitric oxide donors, have shown limited potential in treating cutaneous infection. However, more recent developments in nitric oxide delivery, using nitric oxide nanoparticle technology, demonstrate substantial promise in the promotion of wound repair and eradication of skin and soft tissue infections.Journal of Clinical and Aesthetic Dermatology 06/2010; 3(6):45-50.